Tau is traditionally recognized as a microtubule-binding protein and has gained significant notoriety because it comprises hallmark pathological lesions in a group of diseases known as tauopathies, including Alzheimer’s disease (AD). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.